Literature DB >> 15652902

Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary.

Anneli Stavreus-Evers1, Linn Koraen, Jennifer E Scott, Pu Zhang, Pär Westlund.   

Abstract

OBJECTIVE: To identify the distribution of the enzymes cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A(2) (cPLA(2)) in the human ovary and endometrium.
DESIGN: Prospective clinical study.
SETTING: Hospital-based unit for reproductive health and research laboratories. PATIENT(S): Twenty-nine healthy fertile women with normal menstrual cycles. INTERVENTION(S): Endometrial and ovarian biopsy samples were obtained from healthy, fertile women in the luteal phase of the menstrual cycle or during caesarean section. MAIN OUTCOME MEASURE(S): Pinopode formation and immunohistochemical staining of cPLA(2), COX-1, and COX-2. RESULT(S): In the endometrium, the immunostaining of cPLA(2) was most intense in the luminal epithelium when pinopodes were present. The staining of both COX-1 and COX-2 was most intense in the epithelial cells, with the stroma staining positive only for COX-2. The endometrial vessels expressed COX-2 but not COX-1. The staining of COX-1 and COX-2 was intense on the surface epithelial cells on the outer lining of the ovary. CONCLUSION(S): This study details the distribution of these prostaglandin synthase enzymes and emphasizes their importance for the functions of both the endometrium and the ovary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652902     DOI: 10.1016/j.fertnstert.2004.06.057

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  12 in total

1.  The evolution of menstruation: a new model for genetic assimilation: explaining molecular origins of maternal responses to fetal invasiveness.

Authors:  Deena Emera; Roberto Romero; Günter Wagner
Journal:  Bioessays       Date:  2011-11-07       Impact factor: 4.345

Review 2.  Cadence of procreation: orchestrating embryo-uterine interactions.

Authors:  Jeeyeon Cha; Sudhansu K Dey
Journal:  Semin Cell Dev Biol       Date:  2014-05-23       Impact factor: 7.727

3.  Group IVA phospholipase A₂ optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2.

Authors:  Shiro Kurusu; Adam Sapirstein; Joseph V Bonventre
Journal:  FASEB J       Date:  2012-06-06       Impact factor: 5.191

4.  Endocannabinoid regulation in human endometrium across the menstrual cycle.

Authors:  Jessica G Scotchie; Ricardo F Savaris; Caitlin E Martin; Steven L Young
Journal:  Reprod Sci       Date:  2014-05-12       Impact factor: 3.060

Review 5.  Mechanisms of implantation: strategies for successful pregnancy.

Authors:  Jeeyeon Cha; Xiaofei Sun; Sudhansu K Dey
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

Review 6.  Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics.

Authors:  L Aghajanova; A E Hamilton; L C Giudice
Journal:  Semin Cell Dev Biol       Date:  2007-10-22       Impact factor: 7.727

7.  Restoration of on-time embryo implantation corrects the timing of parturition in cytosolic phospholipase A2 group IVA deficient mice.

Authors:  Naoko Brown; Jason D Morrow; James C Slaughter; Bibhash C Paria; Jeff Reese
Journal:  Biol Reprod       Date:  2009-08-14       Impact factor: 4.285

Review 8.  Delineating the prime mover action of progesterone for endometrial receptivity in primates.

Authors:  D Ghosh; J Sengupta
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

9.  Correlation of IL-1 and HB-EGF with endometrial receptivity.

Authors:  Hui Wang; Guangwen Shi; Ming Li; Hong Fan; Hong Ma; Li Sheng
Journal:  Exp Ther Med       Date:  2018-10-09       Impact factor: 2.447

10.  Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?

Authors:  Nina Zidar; Katarina Odar; Damjan Glavac; Maja Jerse; Tomaz Zupanc; Dusan Stajer
Journal:  J Cell Mol Med       Date:  2008-07-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.